Medicine & Life Sciences

1. Inflammasomes 100%
2. Interleukin-1 68%
3. Hepatic Stellate Cells 57%
4. Purinergic Receptors 41%
5. Matrix Metalloproteinases 39%
6. Cytokines 38%
7. Uric Acid 34%
8. NLR Proteins 31%
9. Extracellular Matrix 31%
10. Macrophages 29%
11. Fibrosis 26%
12. Tissue Inhibitor of Metalloproteinases 25%
13. Purinergic P2X7 Receptors 24%
14. Matrix Metalloproteinase Inhibitors 23%
15. Collagen 23%
16. Fatty Liver 22%
17. Macrophage Activation 20%
18. Lipopolysaccharides 19%
19. Focal Adhesion Protein-Tyrosine Kinases 19%
20. Palmitates 19%
21. Interleukin-8 18%
22. High-Intensity Interval Training 18%
23. Liver 17%
24. Endotoxins 15%
25. Inflammation 15%
26. Mitogen-Activated Protein Kinases 15%
27. Microbiota 15%
28. Keratinocytes 15%
29. Cardiac Myocytes 14%
30. Interleukin-6 13%
31. Hepatocytes 13%
32. canakinumab 12%
33. Reactive Oxygen Species 12%
34. Tissue Inhibitor of Metalloproteinase-1 12%
35. Proteins 12%
36. Adenosine Triphosphate 12%
37. B-Lymphocytes 12%
38. Chemokine CCL8 10%
39. Interleukin 1 Receptor Antagonist Protein 10%
40. THP-1 Cells 9%
41. Pluripotent Stem Cells 9%
42. p38 Mitogen-Activated Protein Kinases 8%
43. Therapeutics 7%
44. (N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide) 7%
45. Liver Cirrhosis 7%
46. Genes 7%
47. Chemokines 7%
48. Down-Regulation 7%
49. Toll-Like Receptors 6%